AWS launches a new AI agent platform specifically for health care

AWS launches a new AI agent platform specifically for health care

Amazon Web Services announced Thursday the launch of Amazon Connect Health. This AI agent-powered platform is meant to help health care organizations automate repetitive administrative tasks including appointment scheduling, documentation, and patient verification, among other things. Amazon Connect Health is HIPAA eligible and connects with electronic health record (EHR) software. The platform is currently partnered…

Read More
China’s brain-computer interface industry is racing ahead

China’s brain-computer interface industry is racing ahead

While Elon Musk’s Neuralink likes to say it’s “pioneering” brain-computer interfaces (BCIs), China’s BCI industry is already quietly moving from research to scale. A new wave of startups is racing to commercialize both implantable and noninvasive BCIs, backed by stronger policy support, expanding clinical trials, and growing investor interest. So says Phoenix Peng, who has…

Read More
7 days until ticket prices rise for Disrupt 2026

7 days until ticket prices rise for Disrupt 2026

Super Early Bird pricing for TechCrunch Disrupt 2026 ends February 27 at 11:59 p.m. PT. That gives you one week to secure the biggest savings of the year — up to $680 off individual passes and up to 30% off community passes. Register now to lock in at the lowest rate. From October 13-15 at Moscone West in San Francisco,…

Read More
BioticsAI, which won Disrupt’s Battlefield competition in 2023, gains FDA approval for its AI-powered fetal ultrasound product 

BioticsAI, which won Disrupt’s Battlefield competition in 2023, gains FDA approval for its AI-powered fetal ultrasound product 

TechCrunch Disrupt Battlefield 2023 winner, BioticsAI, announced on Monday that it has received FDA clearance for its AI software that helps detect fetal abnormalities in ultrasound images.  The product was envisioned by founder CEO Robhy Bustami, who was raised in a family of obstetricians, including his mother, aunt and uncle. He spent a lot of…

Read More
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an expensive scattershot approach — one that is not often successful. However, a new breed of biotech companies are leveraging AI and advanced data technologies in an attempt to accelerate and…

Read More